KhashayarSakhaeeMD
Internal Medicine • Dallas, TXEndocrinology
Professor, Internal Medicine, University of Texas Southwestern Medical Center, Southwestern Medical School
Dr. Sakhaee is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5323 Harry Hines Boulevard
Dallas, TX 75390Phone+1 214-645-0395
Education & Training
Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine, 1976 - 1977
Shiraz University of Medical SciencesClass of 1974
Certifications & Licensure
TX State Medical License 1983 - 2026
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2012
Clinical Trials
- Renal Uptake of Fatty Acids (FFA) in Patients With Idiopathic Uric Acid Nephrolithiasis (IUAN) Start of enrollment: 2017 Jan 01
- Averting Complications of Proton Pump Inhibitor Therapy by Effervescent Calcium Magnesium Citrate Start of enrollment: 2019 Jan 01
- Pathogenesis of Uric Acid Nephrolithiasis: Role of Pioglitazone/Weight Loss Start of enrollment: 2019 Oct 17
Roles: Principal Investigator, Contact
- Join now to see all
Publications & Presentations
PubMed
- Fat Distribution and Urolithiasis Risk Parameters in Uric Acid Stone Formers and Patients with Type 2 Diabetes Mellitus.Alireza Zomorodian, Xilong Li, John Poindexter, Naim M Maalouf, Khashayar Sakhaee
Clinical Journal of the American Society of Nephrology. 2025-01-01 - 1 citationsGaps in kidney stone disease management: From clinical theory to patient reality.Agnieszka Pozdzik, Viridiana Grillo, Khashayar Sakhaee
Urolithiasis. 2024-04-09 - Clinical Images: Vertebral compression fractures and striae in Cushing's disease.Reid Weisberg, Naim Maalouf, Khashayar Sakhaee
ACR Open Rheumatology. 2023-11-01
Grant Support
- Pathogenesis Of Idiopathic Uric Acid Nephrolithiasis: The Role Of Renal LipotoxicNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2012
- Pathophysiology Of Idiopathic Uric Acid NephrolithiasisNational Institute Of Diabetes And Digestive And Kidney Diseases2004–2008
- Post-Transplant Phosphaturia: Duration And PathogenesisNational Center For Research Resources2007
- Medical Evaluation And Treatment Of OsteoporosisNational Center For Research Resources2007
- K Citrate And Stone Risk In Patients On TopiramateNational Center For Research Resources2007
- Combined Sodium Fluoride Amp;Calcium Citrate Therapy In OsteoporosisNational Center For Research Resources2007
- Alternative Assessment Of Intestinal Calcium AbsorptionNational Center For Research Resources2006–2007
- Effect Of Potassium Alkali On Bone Loss And Stone Risk Induced By Atkins'DietNational Center For Research Resources2005–2007
- Diurnal Variation Of Urinary PHNational Center For Research Resources2005–2007
- Integrated Assessment Of Calcium MetabolismNational Center For Research Resources2004–2007
- Pathophysiology And Molecular Genetic Basis Of Gouty DiathesisNational Center For Research Resources1998–2007
- Combined Sodium Fluoride &Calcium Citrate Therapy In OsteoporosisNational Center For Research Resources2004–2006
- Stone Risk Of Estrogen In Early And LATE MenopauseNational Center For Research Resources2004–2005
- Effects Of Smoking And Smoking Cessation On Bone Mineral MetabolismNational Center For Research Resources2004
- Combined Treatment In The Prevention Of Postmenopausal Bone LossNational Center For Research Resources2004
- Hydrochlorothiazide And 1,25-(Oh)(2) Vitamin D In OsteoporosisNational Center For Research Resources1995–2004
- Assessment Of Toxic Skeletal Fluoride ThresholdNational Center For Research Resources1995–2004
- Gouty Diathesis--Pathophysiology And Molecular Genetic BasisNational Institute Of Diabetes And Digestive And Kidney Diseases1999–2002
- Bone Sparing Action Of K MAG Citrate: Comparison W/ Calcium CitrateNational Center For Research Resources1999–2002
- Pharmacokinetics Of Bioequivalent Doses Of FluoridesNational Center For Research Resources1998–2002
- Physiological And Genetic Elucidation Of Gouty DiathesisNational Center For Research Resources1997–2002
- Fluoride Bioavailablity--Effect Of Standard Breakfast And CitracalNational Center For Research Resources1997–2002
- Effect Of Enalapril On Urinary Citrate ExcretionNational Center For Research Resources1997–2002
- Urophos-K For The Treatment Of Idiopathic OsteoporosisNational Center For Research Resources1995–2002
- Combined Sodium Fluoride And Calcium Citrate Therapy In OsteoporosisNational Center For Research Resources1995–2002
- Calcium Citrate And Propensity For Crystallization Of Calcium SaltsNational Center For Research Resources1995–2002
- Pathophysiology &Molecular Genetic Basis Of Gouty DiathesisNational Center For Research Resources2000
- Bone Sparing Action Of K MAG Citrate--Comparison W/ Calcium CitrateNational Center For Research Resources2000
- Assessment Of Calcium Metabolism In Disorder Of Mineral MetabolismNational Center For Research Resources2000
- Novel Treatment For Cystinuria And Stones Of ImmobilizationNational Institute Of Diabetes And Digestive And Kidney Diseases1996–1999
- Long Term Potassium Citrate Therapy--Assessment Of Skeletal Aluminum StoresNational Center For Research Resources1995–1999
- Aluminum Absorption--Effect Of Calcium Citrate On Aluminum Containing AntacidsNational Center For Research Resources1995–1999
- Effect Of IGF1 In Idiopathic OsteoporosisNational Center For Research Resources1997
- Assessment Of Magnesium DepletionNational Center For Research Resources1995–1997
- Effect Of IGF-1 In Idiopathic OsteoporosisNational Center For Research Resources1995–1996
- Comprehensive Evaluation Of OsteoporosisNational Center For Research Resources1995–1996
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
